Waveguide
Waltham, MA · Healthcare, Information Technology · 11 employees
WaveGuide Corporation develops medical and industrial diagnostic devices built upon a breakthrough handheld nuclear magnetic resonance (NMR) platform. Qualitative and quantitative in-situ analysis spanning applications from biological samples, BioPharma, Food, Oils & Lubricants, THC/Cannabis through medical diagnostics (tuberculosis and ovarian cancer are 513(g) predicate device approved by the US
Funding history
- Seed — $3.0M — May 2025
- Seed — $1.9M — May 2024
- Venture - Series Unknown — $8.3M — Mar 2023
- Venture - Series Unknown — $2.6M — Sep 2021
- Venture - Series Unknown — $2.6M — Jun 2019
Recent signals
- May 08, 2025: Raised $3.0M in Seed
- May 09, 2024: Raised $1.9M in Seed
- Mar 03, 2023: Raised $8.3M in Venture - Series Unknown
- Sep 10, 2021: Raised $2.6M in Venture - Series Unknown
- Jun 05, 2019: Raised $2.6M in Venture - Series Unknown
- Nov 26, 2018: Raised $27.0M in Venture - Series Unknown
- Jun 17, 2015: Raised $27.0M in Venture - Series Unknown
See plans & pricing → Track Waveguide’s funding, hiring, and signals — with verified contacts — on Fundz.